tiprankstipranks
Advertisement
Advertisement

AU:1AD Stock Latest News

AdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma
Company AnnouncementsAdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma
11h ago
1AD
AdAlta to Showcase Promising Mesothelioma CAR-T Data in Investor Webinar
PremiumCompany Announcements
AdAlta to Showcase Promising Mesothelioma CAR-T Data in Investor Webinar
5d ago
1AD
AdAlta plans major share and option issue to expand capital base
PremiumCompany Announcements
AdAlta plans major share and option issue to expand capital base
7d ago
1AD
AdAlta shares placed in trading halt ahead of capital raising announcement
PremiumCompany Announcements
AdAlta shares placed in trading halt ahead of capital raising announcement
12d ago
1AD
AdAlta launches “East-to-West” CAR-T strategy with promising mesothelioma data
PremiumCompany Announcements
AdAlta launches “East-to-West” CAR-T strategy with promising mesothelioma data
12d ago
1AD
AdAlta moves BZDS1901 CAR‑T manufacturing to Australia after promising mesothelioma data
PremiumCompany AnnouncementsAdAlta moves BZDS1901 CAR‑T manufacturing to Australia after promising mesothelioma data
13d ago
1AD
AdAlta taps Oribiotech’s automated platform to scale CAR-T manufacturing in Asia-Pacific
Premium
Company Announcements
AdAlta taps Oribiotech’s automated platform to scale CAR-T manufacturing in Asia-Pacific
21d ago
1AD
AdAlta reshapes board as it pushes East-to-West CAR-T strategy
Premium
Company Announcements
AdAlta reshapes board as it pushes East-to-West CAR-T strategy
25d ago
1AD
AdAlta Options Lapse, Trimming Potential Dilution
PremiumCompany Announcements
AdAlta Options Lapse, Trimming Potential Dilution
1M ago
1AD
AdAlta’s CAR-T therapy delivers strong tumour responses in advanced mesothelioma trial
PremiumCompany Announcements
AdAlta’s CAR-T therapy delivers strong tumour responses in advanced mesothelioma trial
1M ago
1AD
AdAlta secures Canadian patent to complete global AD-214 protection
PremiumCompany Announcements
AdAlta secures Canadian patent to complete global AD-214 protection
2M ago
1AD
AdAlta adds investor relations specialist Fadi Diab to board as it advances East-to-West immunotherapy strategy
PremiumCompany Announcements
AdAlta adds investor relations specialist Fadi Diab to board as it advances East-to-West immunotherapy strategy
2M ago
1AD
AdAlta Appoints Fadi Diab as Director with No Initial Shareholding
PremiumCompany AnnouncementsAdAlta Appoints Fadi Diab as Director with No Initial Shareholding
2M ago
1AD
AdAlta’s AdCella Bolsters Advisory Board to Advance Armoured CAR-T Therapy BZDS1901
Premium
Company Announcements
AdAlta’s AdCella Bolsters Advisory Board to Advance Armoured CAR-T Therapy BZDS1901
2M ago
1AD
AdAlta outlines ‘East to West’ strategy to expand CAR-T access across Australia and SE Asia
Premium
Company Announcements
AdAlta outlines ‘East to West’ strategy to expand CAR-T access across Australia and SE Asia
3M ago
1AD
AdAlta Completes Share and Option Issue to Sophisticated Investors
PremiumCompany Announcements
AdAlta Completes Share and Option Issue to Sophisticated Investors
3M ago
1AD
AdAlta Seeks ASX Quotation for New Shares and Options
PremiumCompany Announcements
AdAlta Seeks ASX Quotation for New Shares and Options
3M ago
1AD
AdAlta Seeks ASX Quotation for 240m New Shares and 120m Options
PremiumCompany Announcements
AdAlta Seeks ASX Quotation for 240m New Shares and 120m Options
3M ago
1AD
AdAlta’s AdCella Gains Tailwind from FDA Shift as BZDS1901 Milestone and R&D Rebate Strengthen ‘East to West’ Strategy
PremiumCompany Announcements
AdAlta’s AdCella Gains Tailwind from FDA Shift as BZDS1901 Milestone and R&D Rebate Strengthen ‘East to West’ Strategy
4M ago
1AD
AdAlta outlines “East to West” strategy and first-in-class CAR-T program
PremiumCompany AnnouncementsAdAlta outlines “East to West” strategy and first-in-class CAR-T program
4M ago
1AD
AdAlta Schedules Investor Webinar on CAR-T Deal and ‘East to West’ Strategy
Premium
Company Announcements
AdAlta Schedules Investor Webinar on CAR-T Deal and ‘East to West’ Strategy
4M ago
1AD
AdAlta Plans Significant New Share and Option Issue on ASX
Premium
Company Announcements
AdAlta Plans Significant New Share and Option Issue on ASX
4M ago
1AD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >